We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New FDA Drug Approval Pathway Could Ease Enrichment Trials
New FDA Drug Approval Pathway Could Ease Enrichment Trials
January 30, 2013
The FDA is considering a new drug approval pathway intended to boost development of treatments targeting small subgroups of patients with serious or life-threatening conditions.